Quest Pharmatech Inc.(QPT-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.035
Day High0.035
Open:0.035
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
Quest PharmaTech Announces Results from AGM
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
Quest PharmaTech Announces Results from AGM

Profile

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center.